Dr Lars Klinge Professor Hanns Lochmuller
| Mutation Update and Genotype-Phenotype Correlations of Novel and Previously Described Mutations in TPM2 and TPM3 Causing Congenital Myopathies | 2014 |
|
Dr Lars Klinge Dr Richard Charlton Dr Steven Laval Dr Mark Hornsey Professor Volker Straub et al. | Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle | 2010 |
|
Dr Lars Klinge Dr Michelle Eagle Dr John Hudson Dr Anna Sarkozy Dr Richard Charlton et al. | New aspects on patients affected by dysferlin deficient muscular dystrophy | 2010 |
|
Yen-Hui Chiu Dr Mark Hornsey Dr Lars Klinge Dr Louise Jorgensen Dr Steven Laval et al. | Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy | 2009 |
|
Dr Steven Laval Dr Louise Jorgensen Dr Mark Hornsey Dr Lars Klinge Dr Richard Charlton et al. | Attenuated muscle regeneration is a key factor in dysferlinopathy | 2009 |
|
Dr Mark Hornsey Yen-Hui Chiu Dr Louise Jorgensen Dr Lars Klinge Dr Steven Laval et al. | The evaluation of novel therapeutic strategies for the treatment of dysferlinopathy | 2009 |
|
Dr Lars Klinge Dr Steven Laval Dr Rita Barresi Professor Hanns Lochmuller Professor Volker Straub et al. | G.P.10.05:Preclinical drug trials in vestigating potential treatments for dysferlin deficiency | 2008 |
|
Dr Lars Klinge Dr Steven Laval Dr Mark Hornsey Yen-Hui Chiu Professor Volker Straub et al. | G.P.10.06: Abnormal T-tubule morphology in dysferlin deficient muscle | 2008 |
|
Dr Lars Klinge Dr Richard Charlton Dr Juliane Mueller Dr Louise VB Anderson Professor Volker Straub et al. | Late onset in dysferlinopathy widens the clinical spectrum | 2008 |
|
Dr Lars Klinge Dr Richard Charlton Dr Rita Barresi Emerita Professor Katherine Bushby Professor Volker Straub et al. | Sarcoglycanopathies: Can muscle immunoanalysis predict the genotype? | 2008 |
|
Dr Lars Klinge Professor Robin Harris Dr Richard Charlton Professor Volker Straub Dr Rita Barresi et al. | Dysferlin in muscle regeneration | 2007 |
|
Dr Lars Klinge Dr Richard Charlton Dr Rita Barresi Emerita Professor Katherine Bushby
| Dysferlinopathy with very late onset and untypical clinical presentation | 2007 |
|
Dr Lars Klinge Dr Steven Laval Sharon Foster Faye Haldane Professor Volker Straub et al. | From T-tubule to sarcolemma: Damage-induced dysferlin translocation in early myogenesis | 2007 |
|
Dr Lars Klinge Dr Steven Laval Professor Volker Straub Dr Rita Barresi Emerita Professor Katherine Bushby et al. | Membrane damage induces dysferlin translocation in early myogenesis | 2007 |
|
Dr Lars Klinge Dr Steven Laval Professor Volker Straub Emerita Professor Katherine Bushby
| Damage-induced dysferlin translocation in C2C12 myotubes requires the full length protein | 2006 |
|
Dr Richard Charlton Dr Lars Klinge Emerita Professor Katherine Bushby Professor Volker Straub
| Sarcoglycanopathy - Can immunoanalyses accurately predict the genotype? | 2006 |
|
Dr Lars Klinge Dr Michelle Eagle Professor Volker Straub Emerita Professor Katherine Bushby
| Severe phenotype in infantile facioscapulohumeral muscular dystrophy | 2006 |
|
Dr Lars Klinge Professor Volker Straub
| Enzyme replacement therapy in classical infantile Pompe disease: Results of a ten-month follow-up study | 2005 |
|
Dr Lars Klinge Professor Volker Straub
| Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial | 2005 |
|